A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMRI.
Porpiglia F, Checcucci E, DE Cillis S, Piramide F, Amparore D, Piana A, Volpi G, Granato S, Zamengo D, Stura I, Alladio E, Migliaretti G, DE Luca S, Bollito E, Gned D, DI Dio M, Autorino R, Manfredi M, Fiori C.
Porpiglia F, et al. Among authors: gned d.
Minerva Urol Nephrol. 2023 Feb;75(1):31-41. doi: 10.23736/S2724-6051.22.05189-8. Epub 2023 Jan 10.
Minerva Urol Nephrol. 2023.
PMID: 36626117
Free article.
Clinical Trial.